Bin Yu
Hebei Medical University(CN)University of Shanghai for Science and Technology(CN)Hebei North University(CN)Moffitt Cancer Center(US)Fourth Hospital of Hebei Medical University(CN)ZheJiang Academy of Agricultural Sciences(CN)First Affiliated Hospital of Zhengzhou University(CN)University of Chinese Academy of Sciences(CN)
Publications by Year
Research Areas
CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Colorectal Cancer Surgical Treatments, Ferroptosis and cancer prognosis
Most-Cited Works
- → Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein(2008)885 cited
- → Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma(2013)529 cited
- All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.(2003)
- → Stat3 regulates genes common to both wound healing and cancer(2005)394 cited
- → Safety, Correlative Markers, and Clinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma(2014)254 cited
- → Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab(2016)247 cited